nanotechnology, nanotechnology links, nanomaterials, nanomaterial database, nanotechnology news
.
Nanowerk article print Printer-friendly
Nanowerk article email E-mail this article
Nanowerk news digest Daily News Email Digest
Nanowerk News Feeds News Feeds
Nanowerk on Facebook Join us on Facebook
Nanowerk on Twitter Follow us on Twitter
Bookmark Nanowerk Directory
 
Posted: Feb 13th, 2012
Posted: Feb 13th, 2012
Posted: Feb 13th, 2012
Posted: Feb 13th, 2012
Posted: Feb 13th, 2012
Posted: Feb 13th, 2012
Posted: Feb 13th, 2012
Posted: Feb 9th, 2012
Posted: Feb 9th, 2012
Posted: Feb 9th, 2012
Posted: Feb 8th, 2012
Posted: Feb 8th, 2012
Posted: Feb 8th, 2012
Posted: Feb 7th, 2012
Posted: Feb 7th, 2012
Posted: Feb 7th, 2012
Posted: Feb 7th, 2012
Posted: Feb 7th, 2012
Posted: Feb 6th, 2012
Posted: Feb 6th, 2012
 
Posted: March 18, 2010
Novel Imaging Software Released by Celsense
(Nanowerk News) Celsense, Inc. announced today its launch of the first off-the-shelf software for merging scanner images. The software, dubbed Voxel Tracker™, was designed to optimize the use of Celsense’ imaging reagents but will be made available to any researcher wanting to benefit from the ability to merge scanner images.
Voxel Tracker™ is designed to allow researchers to manipulate and quantify molecular imaging data by merging images produced from different imaging scanners.
When used in conjunction with Celsense imaging reagents, Voxel Tracker™ optimizes the utility of imaging data by allowing researchers to quantify cells and/or inflammation in vivo in a specific region of interest. This is accomplished by merging the images in question. For example, merging NMR and MRI images when using the reagent Cell Sense provides researchers with spatial data pertaining to cell location and biodistribution that is otherwise unavailable.
Celsense contracted with Umlaut Software to develop Voxel Tracker™ after its market research demonstrated that existing ad hoc methods to manipulate and quantify molecular imaging data produced less than satisfactory results. The software is powered by Umlaut Software's VoxPort, a platform of software solutions and tools to manage, deliver, and analyze large volumes of imagery and metadata in rigorous production environments. Umlaut will provide ongoing production and technical support to Celsense Inc. and its customers.
A web based version of the Voxel Tracker™ is available by annual subscription and will be accessed by users via the online portal at voxeltracker.com. The workstation version of Voxel Tracker™ will be available later this year.
Celsense, Inc. has three reagents for MRI imaging of cells currently on the market for pre-clinical research and discovery. The company also offers Voxel Tracker workstation software that maximizes the Cell Sense MRI data set. Customers include leading pharmaceutical and biotechnology companies and medical research centers worldwide.
About Voxel Tracker™
Voxel Tracker™ is a powerful software product that optimizes the use of Celsense imaging reagents. The Voxel Tracker™ software program enables rapid visualization and quantification of MRI-labeled cells. The image processing toolbox fuses and visualizes three-dimensional 1H and 19F images. Powerful, built-in, computational tools enable cell or inflammation quantification in regions of interest, thus enriching the utility of in vivo data. Voxel Tracker™ is currently offered via convenient web-based access. A workstation version of Voxel Tracker™ will be available later this year. See celsense.com/software for more information.
About Celsense, Inc.
Celsense, Inc. offers products that enable the non-invasive imaging of cells in vivo using MRI. The mission of the company is to be the standard for cellular imaging in human health.
Source: Celsense (press release)

Subscribe to a free copy of our daily

Nanowerk Nanotechnology News Email Digest

with a compilation of all of the day's news.

 
 
 
 
Privacy statement | Terms of use | Contact us | Home | Sitemap | Advertise with us
The contents of this site are copyright ©2012, Nanowerk. All Rights Reserved